Citigroup Inc Vaxart, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Vaxart, Inc. stock. As of the latest transaction made, Citigroup Inc holds 3 shares of VXRT stock, worth $2. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 3 -0.0%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.53 - $1.3 $132,960 - $326,129	-250,869 Reduced 100.0%	3 $0
Q1 2024 May 10, 2024	BUY	$0.56 - $1.41 $140,486 - $353,725	250,869 Added 8362300.0%	250,872 $326,000
Q2 2023 Aug 10, 2023	BUY	$0.6 - $1.41 $1 - $4	3 New	3 $0
Q4 2022 Feb 09, 2023	SELL	$0.75 - $2.24 $718,167 - $2.14 Million	-957,557 Reduced 99.9%	952 $0
Q3 2022 Nov 10, 2022	BUY	$2.09 - $4.5 $858,245 - $1.85 Million	410,644 Added 74.95%	958,509 $2.09 Million
Q2 2022 Aug 10, 2022	BUY	$2.7 - $5.28 $1.04 Million - $2.04 Million	385,738 Added 237.92%	547,865 $1.92 Million
Q1 2022 May 12, 2022	SELL	$4.29 - $6.64 $2.14 Million - $3.31 Million	-498,851 Reduced 75.47%	162,127 $817,000
Q4 2021 Feb 10, 2022	BUY	$5.77 - $7.96 $2.45 Million - $3.38 Million	424,746 Added 179.8%	660,978 $4.14 Million
Q3 2021 Nov 10, 2021	BUY	$6.67 - $9.8 $1.58 Million - $2.32 Million	236,232 New	236,232 $1.88 Million

Others Institutions Holding VXRT

# of Institutions

108

Shares Held

37.7M

Call Options Held

188K

Put Options Held

180K

Sio Capital Management, LLC New York, NY

13.6M
Shares

$10.1 Million
6.11% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$7.46 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.97M
Shares

$2.94 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

2.54M
Shares

$1.88 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.77M
Shares

$1.31 Million
0.0% of portfolio

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $93.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account